Impact of a Novel HIV Peer Navigation and Overdose Prevention Intervention on Engagement in the HIV Prevention and Treatment Cascade
Through the proposed Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement (SCOPE) study, the investigators will design and evaluate an overdose prevention and HIV prevention study among people who use drugs (PWUD). Specifically, SCOPE will provide access to drug-checking services for PWUD to better understand the contents of the drug supply, in combination with PrEP for those who are HIV-, to both reduce overdose and HIV among PWUD in Baltimore City.
• 18 years or older,
• self-reports having used illicit stimulants or opioids at least once in the past 3 months,
• self-reports being HIV negative
• reports injection drug use in the past 6 months OR reports at least one of the following indicators of sexual HIV risk exposure in the past 6 months:
‣ Sexually Transmitted Infection (STI) diagnosis in the past 6 months
⁃ Condom-less vaginal or anal sex in the past 6 months
• Willing to provide a urine sample for urine drug screening of substances
• Willing to undergo rapid HIV testing
• Willing to undergo STI testing